Claimable launches first-ever AI-powered appeals platform to fight wrongful healthcare denials

SACRAMENTO, Calif., Oct. 2, 2024 (GLOBE NEWSWIRE) — Claimable, a pioneering healthcare technology company, today announced the launch of an AI-powered appeals platform designed to combat unjustified healthcare denials. The platform uses specially designed artificial intelligence to analyze clinical trials, policy details, appeals data and patients’ unique medical histories, generating and submitting tailored appeals in minutes.

“At Claimable, we are harnessing the power of artificial intelligence to give patients a voice in a system that too often drowns them out,” said Warris Bokhari, CEO and co-founder of Claimable. “Our mission is to level the playing field and ensure that every patient has the opportunity to regain control over their health care and receive the treatment they deserve.”

Claimable pilot results far exceed industry standards:

Appeal success rate of 80% (1.6 times higher than average)
Most cases are resolved in less than 10 days (3 times faster than average)
Appeals made in minutes, not days
Nearly $3 million recovered for patients

This data illustrates the platform’s potential to significantly impact the lives of millions of people and protect patients’ rights in the face of a broken insurance system. Annually, 850 million With 5 billion Health claims in the US are being rejected, leading to delays in patient care 60% affected patients and 47% reporting a deterioration in health as a result. In addition, 100 Millions of Americans have medical debt 66% personal bankruptcy. Claimable is tackling the growing healthcare crisis across the country by empowering patients to quickly challenge unjustified denials, helping them access needed treatments, reducing financial burdens and preventing delays in critical healthcare.

“Claimable’s AI-powered approach is a game changer for patients who have been wrongly denied care,” said Julie Baak, practice manager at Arthritis Center in Bridgeton, Missouri. “It gives them a chance to overturn these decisions and get the right insurance for the right treatment.”

Claimable is currently supporting appeals for 60 life-changing therapies, focusing on drugs commonly denied to people with autoimmune diseases and migraines, which affect nearly 65 million Americans, including 80–85% are women. The company aims to rapidly expand its impact by expanding its offering to over 100 treatments in early 2025. This growth will include support for patients with multiple sclerosis, heart disease, diabetes, obesity, asthma and those battling certain cancers.

“The health care system in this country is fundamentally broken, and millions of patients have been denied the care they need because of for-profit practices,” said Wendell Potter, a claims consultant, health insurance reform expert and former insurance executive. “Claimable offers a critical solution. This platform is a salvation for people caught in the machine of an industry that too often puts money before life.”

The platform’s appeals tool offers intelligent document scanning, a dynamic health questionnaire and instant evidence matching. Unlike static form-based tools, Claimable provides a personalized experience that adapts to responses in real time. Each appeal generated provides a compelling, fact-based narrative tailored to the patient’s unique circumstances and history.

Claimable is now available nationwide and accepts denials from all insurers, including Medicare, Medicaid, United Healthcare, Anthem, Aetna, Cigna and BCBS plans. The applicant submits appeals by fax and first-class mail, requesting urgent, 72-hour processing, if necessary. For affordability reasons, Claimable charges a cancellation fee of $39.95 plus shipping costs.

For more information about Claimable or to join the waitlist for future terms, visit www.getclaimable.com.

Claim information:
Claimable is revolutionizing the way patients fight health care denials by helping ensure everyone has access to the care they need and the coverage they deserve. The platform uses purpose-built artificial intelligence to analyze clinical trials, policy details, appeals data and patients’ unique medical histories, generating and submitting tailored appeals in minutes. Claims are available nationwide and accept denials from all insurers, including Medicare and Medicaid. As a member of the NVIDIA Inception Program, Claimable continues to push the boundaries of AI innovation in healthcare. More information can be found at https://www.getclaimable.com/.

Contact:
Emily Fox
[email protected]